[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358862-105":59,"doc-detail-358862-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-impact-of-tumour-deposits-across-n-stages-in-stage-iii-colon-cancer-development-and-validation-of-a-novel-n-staging-system-using-the-seer-database-and-a-chinese-single-centre-cohort","Prognostic impact of tumour deposits across N stages in stage III colon cancer - development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort","","Evaluation of tumour deposit (TD) count across N stages in stage III colon cancer focuses on cancer-specific survival (CSS) and aims to create and verify a novel N staging approach that incorporates TD. Retrospective analysis uses SEER population data with external validation from a single-centre cohort in South China. TD predicts worse CSS and the model converts TD into metastatic lymph node equivalents, improving prognostic accuracy versus AJCC staging.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-impact-of-tumour-deposits-across-n-stages-in-stage-iii-colon-cancer-development-and-validation-of-a-novel-n-staging-system-using-the-seer-database-and-a-chinese-single-centre-cohort/358862/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-impact-of-tumour-deposits-across-n-stages-in-stage-iii-colon-cancer-development-and-validation-of-a-novel-n-staging-system-using-the-seer-database-and-a-chinese-single-centre-cohort/358862.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To assess how tumour deposit (TD) affects prognosis across different N stages in stage III colon cancer and to develop and validate a novel N staging system that includes TD count to improve prediction of cancer-specific survival (CSS).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources were used for development and validation?",{"text":117,"@type":113},"Development relied on SEER database data (2010–2017), and external validation used an independent single-centre cohort from South China (2015–2019).",{"name":119,"@type":110,"acceptedAnswer":120},"How was TD incorporated into the proposed N staging system?",{"text":121,"@type":113},"TD counts were converted into metastatic lymph node equivalents using weightings by N stage, then stratified into nN1a, nN1b, nN2a and nN2b categories, with performance compared against AJCC N staging using AUC and Brier scores.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},358862,1790178580,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Open access  \nTo cite: Lam W, Yang Z, Lyu Z, et al. Prognostic impact of tumour deposits across N stages in stage III colon cancer: development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort. BMJ Open 2026;16:e099489 . doi:10 . 1136/ bmjopen-2025-099489  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2025-099489](bmjopen-2025-099489)) .  \nWL and ZY contributed equally.  \nReceived 18 January 2025 Accepted 27 January 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDeqing Wu; [wudeqing@gdph.org.cn](wudeqing@gdph.org.cn) and Guole Lin; [linguole@126.com](linguole@126.com)  \nOriginal research  \nPrognostic impact of tumour deposits across N stages in stage III colon cancer:  \ndevelopment and validation of a novel N staging system using the SEER database and a Chinese singlecentre cohort  \nWaiting Lam,1 Zifeng Yang,2 Zejian Lyu,2 Guole Lin,3 Deqing Wu  2  \nABSTRACT  \nObjectives To evaluate the prognostic significance of tumour deposit (TD) across different N stages in patients with stage III colon cancer and to develop and validate a novel N staging system that incorporates TD count to improve prediction of cancer-specific survival (CSS) . Design Retrospective cohort study based on populationbased data and external validation.  \nSetting Secondary and tertiary care settings; data from the SEER database, a population-based cancer registry capturing cancer incidence and survival information (USA, 2010–2017); and a single-centre validation cohort from South China (2015–2019) .  \nParticipants A total of 8739 stage III colon cancer patients from the SEER database who underwent curative surgery were included; 1335 (15 .3%) had TD. Patients with \u003C12 examined lymph nodes and those who received neoadjuvant therapy were excluded. An independent external validation cohort included 326 patients from Guangdong Provincial People’s Hospital. Selection criteria were consistent with the SEER cohort.  \nOutcome measures The outcome was cancer-specific survival (CSS) . The prognostic impact of tumour deposit (TD) and the comparative performance of the novel N staging system versus the AJCC system were evaluated using the Fine-Gray competing risks model, timedependent area under the curve (AUC) and Brier score. Results TD was independently associated with poorer CSS: 1 TD (SHR=1 .23, 95% CI 1.04 to 1 .47, p=0 .017), 2–3 TDs (SHR=1 .36, 95% CI 1.17 to 1 .58, p\u003C0 .001) and >3 TDs (SHR=2 .02, 95% CI 1.73 to 2 .35, p\u003C0 .001) . The adverse effect of TD was more pronounced in N1 compared with N2 patients. Based on these findings and the work of Mayo et al, TDs were converted to metastatic lymph nodes (mLNs) using the following weighting: 1 TD=3 mLNs (N1c), 1 TD=2 mLNs (N1) and 1 TD=1 mLN (N2) . The novel N staging system stratified patients as nN1a (1 nLN), nN1b (2–3 nLNs), nN2a (4–6 nLNs) and nN2b (≥7 nLNs) . This approach showed improved prognostic accuracy compared with AJCC N staging: 3-year AUC (0 .623 vs 0 .614) and Brier score (0 .151 vs 0 . 157, p\u003C0 .001) . A similar performance was observed in the  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ The study used a large, population-based dataset (SEER) covering 17 US cancer registries, enhancing generalisability across diverse demographic and clinical backgrounds.  \n⇒ Clear and rigorous inclusion/exclusion criteria were applied, including only patients with ≥12 examined lymph nodes and complete clinical-pathological data, reducing selection bias, and a well-defined and standardised definition of tumour deposits was adopted based on the AJCC seventh edition, ensuring consistency in clas","cbCaigEHgJhr58C8","https://ap.wps.com/l/cbCaigEHgJhr58C8","pdf",959388,"English","# Abstract\n## Objectives\n## Design and setting\n## Participants\n## Outcome measures\n## Key results\n## Strengths and limitations\n## Conclusions\n# Introduction","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To assess how tumour deposit (TD) affects prognosis across different N stages in stage III colon cancer and to develop and validate a novel N staging system that includes TD count to improve prediction of cancer-specific survival (CSS).\"},{\"question\":\"Which data sources were used for development and validation?\",\"answer\":\"Development relied on SEER database data (2010–2017), and external validation used an independent single-centre cohort from South China (2015–2019).\"},{\"question\":\"How was TD incorporated into the proposed N staging system?\",\"answer\":\"TD counts were converted into metastatic lymph node equivalents using weightings by N stage, then stratified into nN1a, nN1b, nN2a and nN2b categories, with performance compared against AJCC N staging using AUC and Brier scores.\"}]","Prognostic impact of tumour deposits across N stages in stage III colon cancer - development and validation of a novel N staging system using the SEER database and a Chinese single-centre cohort | PDF",1790135499,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fae4906b11507f1d2f4448dee4f6be2.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69fdb57a25f435327eed0596ec75b5b5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d39d3916183c62ac5539c4433dd1b6d8.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad09f378b3df790a76ebb4e7fc268388.webp",980,1306]